Basford, Patricia Ann,Campeta, Anthony Michael,Gillmore, Adam,Jones, Matthew Cameron,Kougoulos, Elefherios,Luthra, Suman,Wallton, Robert
申请号：
HRP20191944
公开号：
HRP20191944T1
申请日:
2019.10.25
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyf}-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd]indol-6-one；(I), and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
